Status:
TERMINATED
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
18-45 years
Brief Summary
The primary goal of this study is to identify a gene or panel of genes which are differentially expressed in lung cells and tissue from asthmatic patients following administration of Ipratropium bromi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Have a history of intermittant asthma.
- Have asthma symptoms less than once per week.
- Have no other significant disease.
- Do not take regular oral or inhaled steroids.
- Are a non-smoker for the past 12 months with a pack history of less than 5 years.
- Exclusion criteria:
- Have a history of drug or alcohol abuse.
- Have poorly controlled asthma or a history of life-threatening asthma.
- Have a history of hypersensitivity to bronchodilators.
- Are unable to abstain from inhaled steroids from 14 days prior to the first study visit until completion of the study.
- Have received oral steroids within 3 months of study entry.
- Have been hospitalized for your asthma within 3 months of study entry.
- Have had treatment with an investigational drug within 30 days or 5 half-lives (whichever is longer) preceding the first dose of study medication.
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00331292
Start Date
August 1 2006
Last Update
October 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19104